Eric H. Baehrecke - University Park MD, US Ajjai Alva - Baltimore MD, US Michael J. Lenardo - Potomac MD, US Yu Li - Rockville MD, US
Assignee:
University of Maryland College Park - College Park MD National Institutes of Health - Bethesda MD
International Classification:
C07H 21/02 C07K 16/00
US Classification:
536 231, 5303871
Abstract:
The present invention relates to a new molecular pathway in which activation of the receptor-interacting protein (RIP, a serine-threonine kinase) and Jun N-terminal kinase induce cell death with the morphology of autophagy. Further, autophagic death is induced by caspase 8 inhibition and expression of the mammalian genes ATG7 and beclin.
Polymeric Micellar Complexes And Drug Delivery Vehicles Thereof
Disclosed are complexes of an amphiphilic copolymer, wherein the amphiphilic copolymer has benzoyl sulfonic acid groups on the hydrophobic segment of the copolymer.
Allan James Clarke - Collegeville PA, US David Geoffrey Cullingford - Essex, GB Yu Li - Collegeville PA, US
International Classification:
A61K 9/30 A61K 31/55
US Classification:
424465, 51421701
Abstract:
The present invention relates to a novel dosage form, to a process for preparing the dosage form and to the use of the dosage form in the treatment of neurological and psychiatric disorders.
Allan James Clarke - Collegeville PA, US Ian Paul Conn - Essex, GB Simon Richard Hicks - Essex, GB Yu Li - Collegeville PA, US Xiaolei Wang - Essex, GB
The present invention relates to a novel dosage form, to a process for preparing the dosage form and to the use of the dosage form in the treatment of neurological and psychiatric disorders.
Dosage Form Comprising 1-Isopropyl-4-Hexahydro-1H-1,4-Diazepine Or A Salt Thereof
The invention relates to a dosage form for oral administration comprising a carrier tablet, wherein the carrier tablet is at least partially (preferably partially) covered by a film comprising 1-isopropyl-4-{[4-(tetrahydro-2H-pyran-4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepineor a pharmaceutically acceptable salt thereof, such as the mono-maleate salt thereof.In particular embodiments, the film, which at least partially covers the carrier tablet, comprises a stabiliser (e.g. citric acid), and/or a film former (e.g. hydroxypropylcellulose).The film is preferably present in a recess on the carrier tablet.The invention also relates to a method of producing said dosage form.
Dr. Li graduated from the China Med Univ, Shenyang City, Liaoning, China in 1985. He works in Davenport, IA and 1 other location and specializes in Anatomic Pathology & Clinical Pathology. Dr. Li is affiliated with Trinity Medical Center Moline, Unitypoint Health Trinity, UnityPoint Health Trinity Bettendorf and Unitypoint Health Trinity Regional Medical Center.
Nov 2012 to 2000 Chief Representative of New YorkBEIJING GALLOPING HORSE TV & FILM PRODUCTION New York, NY Aug 2009 to Nov 2012 Assistant Director of Business DevelopmentBARUCH COLLEGE /CUNY
Jun 2008 to Aug 2009 Student Ambassador and Peer Mentor
Education:
FUQUA SCHOOL OF BUSINESS, Duke University Durham, NC 2014 to 2016 Master of Business AdministrationSCHOOL OF CONTINUING AND PROFESSIONAL STUDIES, New York University New York, NY 2013 Advanced ExcelBARUCH COLLEGE, City University of New York New York, NY May 2011 Bachelor of Business Administration in Economics
Skills:
Computer: Microsoft Word, Excel, PowerPoint, Access CFA Level 1 Candidate (June 2014 Exam) Fluent in Mandarin
National University of Singapore - Computer Science, Beijing University of Posts and Telecommunications - Information Engineering
Tagline:
Enjoy life in SG
Yu Li
Education:
Hofstra University - M.B.A. in Finance, New York Institute of Technology - M.S. in Computer Sciense, Tsinghua University - B.S. in Electrical Engineering